stella
beta
Low Dose Radiotherapy Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Stage II-III NSCLC — Stella
Recruiting
Back to NSCLC trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Anhui Provincial Cancer Hospital, Hefei, Anhui
View full record on ClinicalTrials.gov